Monocomponent Human Insulin Tenders

Get complete information related to latest Monocomponent Human Insulin Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Monocomponent Human Insulin Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Monocomponent Human Insulin Tenders .

Filter

Loading....

Get Tender in Email

Central Government/Public Sector

CTN :40956654

11 Jul, 2025 NA

Chittaranjan - West Bengal

Tender For supply of injection somatropin i.p 4 iu (recombinant human growth hormone)(equal quontity syringe and needles to be supplied free of cost ). ]

Central Government/Public Sector

CTN :40423056

09 Jul, 2025 11.49 Crore

Kamrup - Assam

Tender For corrigendum : supply of drugs under group 12. - human chorionic gonadotropin: injection 5000 iu, vial, glimepiride: tablet 1 mg, 1x10, insulin : insulin injection ip soluble insulin, neutral, 40 iu/ml, 10 ml vial, insulin : biphasic isophane insulin injection ip(30% as soluble insulin and 70% as isophane insulin), 40 iu/ml, 10 ml vial, metformin: tablet 500 mg sr, 1x10, metformin: tablet 1000 mg sr, 1x10, empagliflozin : tablet 10 mg, 1x10, linagliptine : tablet 5mg, 1x10, sitagliptin : tablet/capsule 50 mg, 1x7/1x10, carbimazole: tablet 10 mg, 100 tablets in a bottle, levothyroxine: tablet 25 mcg, 100 tablets in a bottle, levothyroxine: tablet 50 mcg, 100 tablets in a bottle, carboprost trometahmine : injection 250 mg/ml, 1 ml amp, methylergometrine: tablet 0.125 mg, 1x10, methylergometrine: injection 0.2 mg/ml, 1 ml amp, mifepristone: tablet 200 mg, 1x1, misoprostol: tablet 200 mcg, 1x4, oxytocin: injection 5 iu/ml, 1 ml amp, recombinant growth hormone : injection per iu , vial/pfs, dutasteride: soft gelatin capsule 0.5mg, 1x10, tamsulosin: tablet 0.4mg mr, 1x10, silodosin : tablet 8mg, 1x10

CTN :40741985

17 Jul, 2025 NA

Karnal - Haryana

Tender For rate contract for supply of insulin drugs for a period of two years from date of conclusion - insulin (soluble) injection 40iu/ml, human insulin 50/50 injection 40iu/ml, human insulin 30/70 injection 40iu/ml, human insulin 30/70 injection 100iu/ml, human insulin 30/70 pen 100iu/ml, basic isophene insulin(25% soluble and 75% isophene) r dna origin 100iu/ml, cart cartridge, basic isophene insulin(50% soluble and 50% isophene) r dna origin 100iu/ml, cart cartridge, basic isophene insulin(50% soluble and 50% isophene) r dna origin 100iu/ml, injection injection, basic isophene insulin(50% soluble and 50% isophene) r dna origin 100iu/ml, pfp pen, basic isophene insulin(50% soluble+50% isophene) r dna origin 40iu/ml, basic isophene insulin(50% soluble+50% isophene) r dna origin 40iu/ml, basic isophene insulin(50% soluble and 50% isophene) r dna origin 40iu/ml, injection injection, basic isophene insulin(30% soluble and 70% isophene) r dna origin 40iu/ml, injection injection, basic isophene insulin(30% soluble and 70% isophene) r dna origin 100iu/ml, cart cartridge, insulin lispro protamin 25% and 75 % 100iu/ml, cart cartridge, insulin analog, rdna, soluble insulin aspart 100iu/ml, injection injection, insulin analog, rdna,soluble insulin aspart 100iu/ml, pfp pen, insulin analog, rdna, soluble insulin aspart 100iu/ml, cart cartridge, insulin detemir 100iu/ml, pfp injection, insulin glargine 100iu/ml, injection injection, insulin glargine 100iu/ml, cart/vial cartridge, insulin glargine 100iu/ml, pfp, insulin (soluble) cartridge 100iu/ml, insulin (soluble) 100iu/ml, pfp, isophane insulin, rdna, monocomponent human insulin, biosynthetic 40iu/ml, injection injection, isophane insulin, rdna, monocomponent human insulin, biosynthetic 100iu/ml, cart cartridge, isophane insulin, rdna, monocomponent human insulin, biosynthetic 100iu/ml, pfp pen, isophane insulin 100iu/ml, injection, premix human insulin analog, rdna, soluble insulin aspart and protamin aspart 100iu/ml, cart cartridge, premix human insulin analog, rdna, soluble insulin aspart and protamin aspart 100iu/ml, pfp pen, dulaglutide injection 1.5 mg, insulin decludec 100iu/ml (3ml) contains insulin degludec (monocomponent biosynthetic r-dna insulin) solution for subcutaneous injection in a pre-filled pen, liraglutide (glucagon-like peptide-1 analogue), 6mg/ml, 3ml (biosynthetic r-dna origin) solution for injection ina prefilled pen for s.c. use, insulin lispro 100iu (100 iu/ml), pfp pen, insulin lispro 50% and lispro protamine 50% (100 iu/ml), pfp pen, insulin lispro 25% and lispro protamine 75% (100 iu/ml), pfp pen, insulin lispro 100iu (100 iu/ml), 3 ml cart cartridge, insulin lispro 50% and lispro protamine 50% (100 iu/ml), 3 ml cart cartridge,

CTN :40711607

02 Jul, 2025 NA

Delhi - Delhi

Tender For supply of pvms no 011747, lutropin alpha-r-dna (recombinant leutinising hormone 75 iu) powder with 1 ml solvent for solution for injection

Loading, Please wait...

Monocomponent Human Insulin Tenders

By Cities

By States

By Agencies

By Ownerships

By Sectors

Central Government/Public Sector

Central Government/Public Sector